The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Glaser Robert since 2005.
The trader's CIK number is 1187187.
At the time of the last reporting, Glaser Robert was the Director of Viropharma Inc. (stock ticker symbol VPHM).
Also see all insider trading activities at Viropharma Inc.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2012 | VPHM | 0 | $0 | 30,000 | $743,370 | 30,000 | $347,250 |
2011 | VPHM | 0 | $0 | 5,000 | $115,000 | 5,000 | $15,000 |
2010 | VPHM | 0 | $0 | 15,000 | $208,750 | 10,000 | $120,000 |
2007 | VPHM | 0 | $0 | 15,000 | $262,689 | 15,000 | $226,874 |
2005 | VPHM | 20,000 | $96,675 | 0 | $0 | 0 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2012-11-30 | VPHM | Option Ex | 30,000 | 11.57 | 347,250 |
2012-11-30 | VPHM | Sale | 30,000 | 24.78 | 743,370 |
2011-11-28 | VPHM | Option Ex | 5,000 | 3.00 | 15,000 |
2011-11-28 | VPHM | Sale | 5,000 | 23.00 | 115,000 |
2010-12-14 | VPHM | Sale | 5,000 | 16.75 | 83,750 |
2010-05-27 | VPHM | Option Ex | 5,000 | 12.00 | 60,000 |
2010-05-27 | VPHM | Sale | 5,000 | 12.50 | 62,500 |
2010-05-27 | VPHM | Option Ex | 5,000 | 12.00 | 60,000 |
2010-05-27 | VPHM | Sale | 5,000 | 12.50 | 62,500 |
2007-02-07 | VPHM | Option Ex | 10,000 | 15.12 | 151,250 |
2007-02-07 | VPHM | Sale | 10,000 | 18.02 | 180,189 |
2007-01-30 | VPHM | Option Ex | 2,500 | 15.12 | 37,812 |
2007-01-30 | VPHM | Sale | 2,500 | 17.00 | 42,500 |
2007-01-25 | VPHM | Sale | 2,500 | 16.00 | 40,000 |
2007-01-25 | VPHM | Option Ex | 2,500 | 15.12 | 37,812 |
2005-06-06 | VPHM | Buy | 12,500 | 5.48 | 68,475 |
2005-05-19 | VPHM | Buy | 7,500 | 3.76 | 28,200 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Glaser Robert (Director of Viropharma Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.